SCHEMBL7062282

SCHEMBL7062282

CC(C)(C)OC(=O)ON(Cc1ccc(C(N)=NOCc2ccc(F)cc2)cc1)OC(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 3/20 0.38
MAOB P27338 2/20 0.38
PKM P14618 2/20 0.38
PARP10 Q53GL7 1/20 0.38
S1PR1 P21453 1/20 0.37
KCNQ4 P56696 3/20 0.36
KCNQ5 Q9NR82 3/20 0.36
RIPK1 Q13546 2/20 0.34
HTT P42858 1/20 0.34
CA12 O43570 1/20 0.34
NR1D1 P20393 1/20 0.34
GRM2 Q14416 1/20 0.34
KCNA5 P22460 1/20 0.33
NR4A2 P43354 1/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7062273 1.00 SMN1; SMN2 (0.39) SMN1; SMN2NPC1RAB9AMAOBPKM
SCHEMBL6684012 0.96 NPC1 (0.37) SMN1; SMN2NPC1RAB9AMAOBPKM
SCHEMBL6650316 0.77 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9AMAOBPKM
Isobutane SCHEMBL7062276 0.71 NPC1 (0.46) SMN1; SMN2NPC1RAB9AMAOBPKM
Hydrochloric Acid SCHEMBL6794609 0.71 MAOB (0.51) SMN1; SMN2NPC1RAB9AMAOBPKM
Hydrochloric Acid SCHEMBL6672174 0.71 MAOB (0.51) SMN1; SMN2NPC1RAB9AMAOBPKM
SCHEMBL18740536 0.70 RIPK1 (0.44) KCNQ4KCNQ5RIPK1NR1D1
Ammonia Solution, Strong SCHEMBL6905116 0.69 SMN1; SMN2 (0.39) SMN1; SMN2NPC1RAB9AMAOBPKM
SCHEMBL8363482 0.69 HDAC3 (0.40) SMN1; SMN2NPC1RAB9AHTTGRM2
SCHEMBL18763349 0.69 RIPK1 (0.43) KCNQ4KCNQ5RIPK1NR1D1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082585-A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082585-A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade TFPI, F2, PLG SMN1; SMN2 4186/4885NPC1 2315/4885RAB9A 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.